Loading insider details...
Beta
Latest Form 4 (Jan 9, 2026): Grant/Award of 4,530,997 CERO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 4,530,997 | n/a |
| Jun 2, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 61,843 | n/a |
| Mar 6, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 119,486 | n/a |
| Feb 26, 2025 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 1,275,000 | n/a |
| Dec 5, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 1,275,000 | n/a |
| Oct 3, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Exercise/Conversion | 5,312,983 | n/a |
| Jun 13, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 800 | n/a |
| Mar 28, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Grant/Award | 572,182 | n/a |
| Feb 21, 2024 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/Award | 2,000 | n/a |
| Feb 17, 2024 | CERO THERAPEUTICS HOLDINGS, INC. (CERO) | Other (see footnotes) | 1,125,000 | n/a |